Rockwell Medical, Inc.
PosiFunda Ratios Only on PositoAI
PositoAI's own ratios from Rockwell Medical, Inc.'s yearly results (2022–2025), compared with Healthcare companies in United States. Tap ? on any ratio for what it means.
Where $100 of sales goes
Latest year (Dec 2025). Taxes and other income are not shown, so the parts need not add up to 100.
Cash quality
Profit Cash Ratio
—Loss-making or profit too small
Over the last 3 years profit was a loss or under 2% of sales, so cash per 100 of profit is not meaningful.
Self-Funding Ratio
-3.2×Over the last 3 years operating cash was negative while the company kept spending on investment (capex).
Higher than 58% of Healthcare companies in United States.
Cash Locked Ratio
$14For every $100 of sales, $14 is tied up in day-to-day operations (money owed by customers + stock − money owed to suppliers), against $11 tied up three years earlier.
Less money tied up than 71% of Healthcare companies in United States.
Growth quality
Steadiness Ratio
2/3 · 2/3Sales grew in 2 of the last 3 years; profit grew in 2 of 3.
Steadier than 69% of Healthcare companies in United States.
Growth Efficiency Ratio
—Sales barely changed
Sales changed by -5% in 3 years, too little to measure extra profit per extra sales.
Asset Productivity Ratio
-5% / +23%In 3 years sales changed by -5% while total assets changed by +23%. Assets grew faster than sales.
Balance-sheet strength
Debt Due Cover Ratio
-2.5×Operating cash was negative last year, while some debt falls due within a year.
Higher than 62% of Healthcare companies in United States.
Cash Cushion Ratio
+44%Cash, after subtracting all debt, equals 44% of its market value (net cash).
Higher than 76% of Healthcare companies in United States.
Tangible Assets Ratio
81%Of every $100 the company owns, $81 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles.
More tangible than 52% of Healthcare companies in United States.
Tangible Net Worth Ratio
71%Of every $100 of net worth, $71 is tangible; the rest is goodwill and other intangibles, often from buying other companies.
More tangible than 58% of Healthcare companies in United States.
Shareholders
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (13)
Rockwell Medical, Inc. made a loss over the last year. Rockwell Medical, Inc. owes $0.38 for every $1 it owns. Rockwell Medical, Inc. made a loss in each of the last two years.
Compared with Healthcare companies in United States · latest annual results Dec 2025.
P/E ratio
LossRockwell Medical, Inc. made a loss over the last year, so its P/E ratio is not meaningful.
P/B ratio
0.81The share price is 0.81 times Rockwell Medical, Inc.'s book value per share, lower than 83% of Healthcare companies in United States.
Market cap
$28 MThe total market value of all of Rockwell Medical, Inc.'s shares at today's price (share price × number of shares), smaller than 80% of Healthcare companies in United States. PosiCap size class: Micro Cap.
Net worth (book value)
$35 MWhat Rockwell Medical, Inc. would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (30 Jun 2026).
Book value per share
$8.70Net worth divided by the number of shares. The share price of $7.06 is 0.8 times this, which is the P/B above.
Return on equity (ROE)
-15.5%Rockwell Medical, Inc. lost 15.5% of its shareholders' money over the last year, higher than 68% of Healthcare companies in United States.
Owes vs Owns
0.38×Rockwell Medical, Inc. owes $0.38 for every $1 it owns (low), lower than 53% of Healthcare companies in United States.
Dividend yield
NoneRockwell Medical, Inc. does not currently pay a dividend.
Revenue growth
-32%Revenue fell 32% in the year to Dec 2025, and shrank 2% a year on average over 3 years.
Profit growth
LossRockwell Medical, Inc. made a loss in each of the last two years.
Profit margin
-7.7%Rockwell Medical, Inc. lost $8 for every $100 of revenue.
Interest cover
Not coveredRockwell Medical, Inc.'s operating profit did not cover its interest costs in the year to Dec 2025.
Cash vs debt
Net cashRockwell Medical, Inc. held $13 M more cash than debt (net cash) at Dec 2025.
Questions
How is P/B calculated on PositoAI?
P/B is market cap divided by net worth from the latest balance sheet. For Rockwell Medical, Inc.: $28 M ÷ $35 M (30 Jun 2026) = 0.8.
What is Rockwell Medical, Inc.'s return on equity?
Rockwell Medical, Inc. lost 15.5% of its shareholders' money over the last year, higher than 68% of Healthcare companies in United States.
How much does Rockwell Medical, Inc. owe compared with what it owns?
Rockwell Medical, Inc. owes $0.38 for every $1 it owns (low), lower than 53% of Healthcare companies in United States.
Does Rockwell Medical, Inc. pay a dividend?
No. Rockwell Medical, Inc. does not currently pay a dividend.
Is Rockwell Medical, Inc.'s revenue growing?
Revenue fell 32% in the year to Dec 2025, and shrank 2% a year on average over 3 years.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.